(Q39498230)

12 September 2017

title

PET/MRI in cancer patients: first experiences and vision from Copenhagen (English)

1 reference

12 September 2017

11

Liselotte Højgaard

0 references

Søren Holm

10

Søren Holm

0 references

Ian Law

3

Ian Law

0 references

Andreas Kjær

Andreas Kjær

1

0 references

Adam Espe Hansen

8

Adam Espe Hansen

1 reference

12 September 2017

9

Sune Keller

1 reference

12 September 2017

Annika Loft

2

1 reference

12 September 2017

Anne Kiil Berthelsen

4

1 reference

12 September 2017

Lise Borgwardt

5

1 reference

12 September 2017

Johan Löfgren

6

1 reference

12 September 2017

Camilla Bardram Johnbeck

7

1 reference

12 September 2017

publication date

25 December 2012

1 reference

Magnetic Resonance Materials in Physics, Biology and Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

26

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

37-47

1 reference

https://scigraph.springernature.com/pub.10.1007/s10334-012-0357-0

12 September 2017

exact match

0 references

cites work

Molecular imaging of cancer with positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

A combined PET/CT scanner: the path to true image fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Predicting and monitoring cancer treatment response with diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Whole-body diffusion-weighted MR imaging in cancer: current status and research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Real-time 3T fMRI data of brain tumour patients for intra-operative localization of primary motor areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Brain perfusion CT compared with ¹⁵O-H₂O PET in patients with primary brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Combined PET/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Clinical applications of PET and PET/CT in pediatric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

[Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

The new EANM paediatric dosage card: additional notes with respect to F-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

The new EANM paediatric dosage card.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Imaging pediatric bone sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

MRI of pulmonary nodules: technique and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Whole-body diffusion-weighted imaging in lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Whole-body MR/PET: applications in abdominal imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Combined PET/MRI: a new dimension in whole-body oncology imaging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

(64)Cu-NODAGA-c(RGDyK) Is a Promising New Angiogenesis PET Tracer: Correlation between Tumor Uptake and Integrin α(V)β(3) Expression in Human Neuroendocrine Tumor Xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10334-012-0357-0

A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT

21 January 2018

1 reference

12 December 2020

Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting

1 reference

12 December 2020

Whole-body MRI for primary evaluation of malignant disease in children

1 reference

12 December 2020

Whole-body diffusion-weighted imaging for staging malignant lymphoma in children

1 reference

12 December 2020

Molecular imaging of cancer using PET and SPECT.

1 reference

12 December 2020

Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective

1 reference

12 December 2020

Diffusion-weighted magnetic resonance imaging of lung cancer at 3.0 T: a preliminary study on monitoring diffusion changes during chemoradiation therapy

1 reference

12 December 2020

MRI for attenuation correction in PET: methods and challenges

1 reference

12 December 2020

In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients

1 reference

12 December 2020

A combined PET/CT scanner for clinical oncology.

1 reference

12 December 2020

10.1007/S10334-012-0357-0

Identifiers

DOI

1 reference

12 September 2017

1 reference